{"id":"placebo-injectable-solution","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, it does not interact with any biological molecules or systems. It is used as a control in clinical trials to compare the effects of active treatments.","oneSentence":"This drug is a placebo, meaning it has no active therapeutic effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:46.189Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07149649","phase":"PHASE2, PHASE3","title":"Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)","status":"NOT_YET_RECRUITING","sponsor":"Swiss Cancer Institute","startDate":"2026-07","conditions":"Metastatic NSCLC - Non-Small Cell Lung Cancer","enrollment":230},{"nctId":"NCT05594862","phase":"NA","title":"Treatment of Crohn's Complex Perianal Fistulas With Tissue Transplantation by Local Injection of Micro-fragmented Autologous Adipose Tissue.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lipogems International spa","startDate":"2023-01-09","conditions":"Crohn Disease","enrollment":80},{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT06464146","phase":"PHASE3","title":"Pain Reduction for Limb Injuries in Pediatric Emergency Departments: Intranasal Fentanyl or Intranasal Ketamine vs Oral Morphine","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-02-26","conditions":"Limb Injury","enrollment":300},{"nctId":"NCT06196879","phase":"PHASE2","title":"A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)","status":"COMPLETED","sponsor":"Upstream Bio Inc.","startDate":"2024-02-27","conditions":"Severe Asthma","enrollment":479},{"nctId":"NCT07497646","phase":"NA","title":"Repeated Bilateral Greater Occipital Nerve Blockade in Chronic Migraine and Chronic Tension-Type Headache","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi","startDate":"2025-01-01","conditions":"Chronic Migraine Headache, Chronic Tension-type Headache","enrollment":290},{"nctId":"NCT04123795","phase":"PHASE3","title":"A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"UCB Biopharma SRL","startDate":"2020-01-21","conditions":"Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Mixed Guttate/Plaque Psoriasis","enrollment":49},{"nctId":"NCT07353307","phase":"PHASE3","title":"A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia After Abdominal Surgery in China.","status":"RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2025-12-30","conditions":"Pain After Abdominal Surgery","enrollment":333},{"nctId":"NCT07277660","phase":"PHASE2","title":"A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis","status":"RECRUITING","sponsor":"UCB Biopharma SRL","startDate":"2025-12-29","conditions":"Atopic Dermatitis","enrollment":160},{"nctId":"NCT05039840","phase":"PHASE2","title":"Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2021-11-10","conditions":"Systemic Lupus Erythematosus","enrollment":109},{"nctId":"NCT06290128","phase":"PHASE3","title":"A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-07-12","conditions":"Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic","enrollment":140},{"nctId":"NCT07498751","phase":"PHASE1","title":"Phase I PK and Safety Study of Ondansetron Inhalation Powder","status":"COMPLETED","sponsor":"Luxena Pharmaceuticals, Inc.","startDate":"2025-03-13","conditions":"Postoperative Nausea and Vomiting","enrollment":24},{"nctId":"NCT07226258","phase":"PHASE3","title":"Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain","status":"RECRUITING","sponsor":"Saol Therapeutics Inc","startDate":"2025-11-07","conditions":"Osteoarthritis Knee Pain","enrollment":150},{"nctId":"NCT07493785","phase":"PHASE2, PHASE3","title":"Dexmedetomidine for Invasive Ventilation In the NEOnate","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2026-06-01","conditions":"Invasive Ventilation, Infant Pain, Infant Discomfort","enrollment":246},{"nctId":"NCT07491146","phase":"PHASE2","title":"Phase II Clinical Study of the Efficacy and Safety of HSK55718 in the Treatment of Abdominal Postoperative Pain","status":"NOT_YET_RECRUITING","sponsor":"Yingyong Zhou,MD,PhD","startDate":"2026-03-25","conditions":"Pain After Abdominal Surgery","enrollment":200},{"nctId":"NCT06676319","phase":"PHASE2","title":"Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-11-07","conditions":"Asthma","enrollment":1147},{"nctId":"NCT06337838","phase":"PHASE3","title":"Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2025-06-09","conditions":"Chronic Kidney Diseases, Acute Kidney Injury, Bleeding","enrollment":100},{"nctId":"NCT05722522","phase":"PHASE3","title":"Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2023-08-10","conditions":"Rotator Cuff Tendinopathy","enrollment":33},{"nctId":"NCT04823585","phase":"PHASE4","title":"Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2021-08-12","conditions":"Asthma, Aspirin-Induced, Chronic Rhinosinusitis With Nasal Polyps","enrollment":95},{"nctId":"NCT07225569","phase":"PHASE2","title":"A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-12-29","conditions":"Hidradenitis Suppurativa","enrollment":144},{"nctId":"NCT05065216","phase":"PHASE2, PHASE3","title":"Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)","status":"RECRUITING","sponsor":"DiaMedica Therapeutics Inc","startDate":"2021-11-07","conditions":"Acute Stroke, Ischemic Stroke, Stroke","enrollment":728},{"nctId":"NCT07088068","phase":"PHASE3","title":"A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-08-06","conditions":"Type 1 Diabetes Mellitus","enrollment":723},{"nctId":"NCT07190222","phase":"PHASE3","title":"Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-09-17","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":942},{"nctId":"NCT07488065","phase":"PHASE1","title":"A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.","startDate":"2026-03-25","conditions":"Atopic Dermatitis","enrollment":90},{"nctId":"NCT07488988","phase":"PHASE2","title":"SCARFREE-001: Verteporfin for Scar Prevention","status":"NOT_YET_RECRUITING","sponsor":"Odense University Hospital","startDate":"2026-06","conditions":"Surgical Scar","enrollment":12},{"nctId":"NCT03663335","phase":"PHASE2","title":"Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-11-28","conditions":"Kidney Transplantation","enrollment":418},{"nctId":"NCT07190209","phase":"PHASE3","title":"Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-09-16","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":942},{"nctId":"NCT05985915","phase":"PHASE3","title":"A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-10-27","conditions":"Sjogrens Syndrome","enrollment":612},{"nctId":"NCT06909565","phase":"PHASE4","title":"Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention","status":"RECRUITING","sponsor":"Duke University","startDate":"2025-07-23","conditions":"Percutaneous Coronary Intervention, Peripheral Endovascular Intervention","enrollment":6000},{"nctId":"NCT07018700","phase":"PHASE3","title":"A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine","status":"RECRUITING","sponsor":"Merz Therapeutics GmbH","startDate":"2025-08-21","conditions":"Episodic Migraine","enrollment":990},{"nctId":"NCT07484230","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Adult Japanese Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"NOT_YET_RECRUITING","sponsor":"Sanofi","startDate":"2026-05-08","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":20},{"nctId":"NCT07018713","phase":"PHASE3","title":"A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine","status":"RECRUITING","sponsor":"Merz Therapeutics GmbH","startDate":"2025-08-21","conditions":"Chronic Migraine","enrollment":780},{"nctId":"NCT03992404","phase":"PHASE3","title":"Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merz Pharmaceuticals GmbH","startDate":"2019-09-16","conditions":"Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury","enrollment":603},{"nctId":"NCT04350138","phase":"PHASE2","title":"Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-12-29","conditions":"Gonococcal Infection","enrollment":2606},{"nctId":"NCT05263206","phase":"PHASE3","title":"Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)","status":"RECRUITING","sponsor":"Sanofi","startDate":"2022-02-15","conditions":"Pruritus","enrollment":284},{"nctId":"NCT06468228","phase":"PHASE3","title":"A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-06-27","conditions":"Hidradenitis Suppurativa","enrollment":1280},{"nctId":"NCT07463183","phase":"PHASE2","title":"A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)","status":"NOT_YET_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-03-30","conditions":"Colitis Ulcerative, Ulcerative Colitis","enrollment":100},{"nctId":"NCT05097287","phase":"PHASE4","title":"Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma","status":"RECRUITING","sponsor":"Sanofi","startDate":"2021-12-16","conditions":"Asthma","enrollment":1324},{"nctId":"NCT06652737","phase":"PHASE1","title":"Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanaria Inc.","startDate":"2025-03-04","conditions":"Malaria Falciparum, Malaria Infection","enrollment":75},{"nctId":"NCT06191315","phase":"PHASE3","title":"Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-01-03","conditions":"Wheezing, Asthma","enrollment":90},{"nctId":"NCT04877691","phase":"PHASE3","title":"Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-06-08","conditions":"Systemic Lupus Erythematosus","enrollment":367},{"nctId":"NCT06229483","phase":"PHASE3","title":"The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies","status":"RECRUITING","sponsor":"Stephen Lownie","startDate":"2024-04-03","conditions":"Brain Tumor, Bleeding","enrollment":102},{"nctId":"NCT07482423","phase":"PHASE1, PHASE2","title":"XVIE to Treat Androgenetic Alopecia (AGA)","status":"NOT_YET_RECRUITING","sponsor":"Restore Biologics Holdings, Inc. dba Xtressé","startDate":"2026-05-01","conditions":"Androgenetic Alopecia","enrollment":30},{"nctId":"NCT06513546","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients","status":"NOT_YET_RECRUITING","sponsor":"PLL TX AUSTRALIA PTY LTD","startDate":"2026-04-08","conditions":"Amyotrophic Lateral Sclerosis, ALS","enrollment":153},{"nctId":"NCT06181435","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2023-12-21","conditions":"Dermatitis Atopic","enrollment":589},{"nctId":"NCT07483346","phase":"PHASE1","title":"IASO-782 in Systemic Lupus Erythematosus","status":"NOT_YET_RECRUITING","sponsor":"Shanghai IASO Biotechnology Co., Ltd","startDate":"2026-04-30","conditions":"SLE - Systemic Lupus Erythematosus","enrollment":20},{"nctId":"NCT07058883","phase":"NA","title":"Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars","status":"RECRUITING","sponsor":"Nordberg Medical AB","startDate":"2026-03-13","conditions":"Acne Scars","enrollment":55},{"nctId":"NCT03304496","phase":"PHASE4","title":"Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.","status":"SUSPENDED","sponsor":"Instituto Nacional de Cardiologia Ignacio Chavez","startDate":"2018-03-30","conditions":"Coronary Artery Disease","enrollment":1400},{"nctId":"NCT05831449","phase":"PHASE3","title":"CPL-01 in the Management of Postoperative Pain After Bunionectomy","status":"COMPLETED","sponsor":"Cali Pharmaceuticals LLC","startDate":"2023-05-22","conditions":"Bunion","enrollment":616},{"nctId":"NCT07479290","phase":"PHASE1","title":"Effect of Local Use of Vitamin D on the Rate of Canine Distillization: a Split Mouth Randomized Control Trial","status":"RECRUITING","sponsor":"Foundation University Islamabad","startDate":"2026-02-20","conditions":"Malocclusion of Anterior Teeth","enrollment":30},{"nctId":"NCT07480161","phase":"PHASE2, PHASE3","title":"Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-12-29","conditions":"Erectile Dysfunction With Diabetes Mellitus","enrollment":90},{"nctId":"NCT06226805","phase":"PHASE2","title":"Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)","status":"RECRUITING","sponsor":"Basking Biosciences, Inc.","startDate":"2024-07-31","conditions":"Acute Ischemic Stroke","enrollment":228},{"nctId":"NCT05547464","phase":"PHASE1, PHASE2","title":"Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioNTech SE","startDate":"2023-07-31","conditions":"Tuberculosis","enrollment":497},{"nctId":"NCT07434024","phase":"NA","title":"Erector Spinae Plane Block for Acute Low Back Pain","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2026-03","conditions":"Non-specific Low Back Pain (NSLBP)","enrollment":300},{"nctId":"NCT07426640","phase":"NA","title":"Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation","status":"COMPLETED","sponsor":"Al Mouwasat Hospital","startDate":"2021-11-01","conditions":"Premature (Early) Ejaculation","enrollment":150},{"nctId":"NCT06102005","phase":"PHASE2","title":"Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma","status":"COMPLETED","sponsor":"Sanofi","startDate":"2023-10-16","conditions":"Asthma","enrollment":685},{"nctId":"NCT05487885","phase":"PHASE4","title":"Anhedonia, Development, and Emotions: Phenotyping and Therapeutics","status":"COMPLETED","sponsor":"Erika Forbes","startDate":"2022-07-22","conditions":"Depression, Anhedonia","enrollment":123},{"nctId":"NCT07466940","phase":"PHASE1","title":"A Clinical Study to Evaluate SM17 in Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"SinoMab BioScience Ltd","startDate":"2025-10-14","conditions":"Atopic Dermatitis, Asthma, Inflammatory Bowel Disease","enrollment":30},{"nctId":"NCT07424144","phase":"PHASE3","title":"An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps","status":"ENROLLING_BY_INVITATION","sponsor":"Sanofi","startDate":"2026-03-12","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":380},{"nctId":"NCT05739383","phase":"PHASE3","title":"A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-03-09","conditions":"Primary Prevention of Atherosclerotic Cardiovascular Disease","enrollment":14078},{"nctId":"NCT06812988","phase":"PHASE2","title":"Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2025-02-28","conditions":"Type 1 Diabetes Mellitus","enrollment":84},{"nctId":"NCT06200467","phase":"PHASE1","title":"A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-03-13","conditions":"Overweight, Obesity","enrollment":110},{"nctId":"NCT07090655","phase":"EARLY_PHASE1","title":"A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal Healthy Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Climb Bio, Inc.","startDate":"2025-08-11","conditions":"Healthy Volunteers","enrollment":38},{"nctId":"NCT05776277","phase":"PHASE3","title":"Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cook MyoSite","startDate":"2024-03-21","conditions":"Fecal Incontinence","enrollment":200},{"nctId":"NCT06813911","phase":"PHASE3","title":"Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-04-30","conditions":"Atherosclerotic Cardiovascular Disease (ASCVD)","enrollment":340},{"nctId":"NCT05856526","phase":"PHASE2, PHASE3","title":"A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2023-06-12","conditions":"Netherton Syndrome","enrollment":43},{"nctId":"NCT06353529","phase":"PHASE4","title":"Postop Pain Management in Pituitary Tumour Patients","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2024-11-25","conditions":"Pituitary, Pain, Postoperative","enrollment":108},{"nctId":"NCT07464431","phase":"PHASE4","title":"Evaluating the Clinical Effectiveness of Sodium Bicarbonate for Critically Ill Patients With Metabolic Acidosis and Acute Kidney Injury","status":"NOT_YET_RECRUITING","sponsor":"Universität Münster","startDate":"2026-03","conditions":"Acute Kidney Injury, Metabolic Acidosis, Critical Illness","enrollment":660},{"nctId":"NCT03953300","phase":"PHASE4","title":"Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2019-10-08","conditions":"Asthma","enrollment":75},{"nctId":"NCT07170917","phase":"PHASE2","title":"Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-11-06","conditions":"Hidradenitis Suppurativa","enrollment":208},{"nctId":"NCT07440576","phase":"NA","title":"Effect of Paracervical Block on Postoperative Pain After vNOTES Uterosacral Ligament Suspension","status":"RECRUITING","sponsor":"Erkan Gol","startDate":"2026-03-09","conditions":"Pelvic Organ Prolapse (POP), Postoperative Pain","enrollment":58},{"nctId":"NCT07262281","phase":"PHASE1","title":"Evaluation of the Safety, Tolerability and Pharmacokinetics of HY6725 in Healthy Adult Participants","status":"RECRUITING","sponsor":"Newsoara Biopharma Co., Ltd.","startDate":"2026-02-06","conditions":"Healthy","enrollment":74},{"nctId":"NCT06015737","phase":"PHASE3","title":"A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-06-29","conditions":"Cutaneous Lupus Erythematosus","enrollment":302},{"nctId":"NCT06868212","phase":"PHASE3","title":"A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-07-11","conditions":"Chronic Spontaneous Urticaria (CSU)","enrollment":400},{"nctId":"NCT07281703","phase":"PHASE1","title":"Evaluation of the Safety, Tolerability and Pharmacokinetics of HY8931 in Healthy Adult Participants","status":"RECRUITING","sponsor":"Newsoara Biopharma Co., Ltd.","startDate":"2026-01-14","conditions":"Healthy","enrollment":60},{"nctId":"NCT07293065","phase":"PHASE3","title":"A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)","status":"ACTIVE_NOT_RECRUITING","sponsor":"MAXVAX Biotechnology Limited Liability Company","startDate":"2025-12-15","conditions":"Herpes Zoster","enrollment":12000},{"nctId":"NCT06834347","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-12","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":210},{"nctId":"NCT06834360","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-06","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":210},{"nctId":"NCT03306615","phase":"PHASE2","title":"Peripheral Modulation of Muscle Stiffness and Spasticity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2021-10-11","conditions":"Muscle Spasticity","enrollment":56},{"nctId":"NCT07457008","phase":"PHASE1","title":"Tolerability & Pharmacokinetics of Ginkgolide B Injection: Single- and Multiple-Ascending Doses in Healthy Subjects","status":"COMPLETED","sponsor":"West China Second University Hospital","startDate":"2021-07-01","conditions":"Healthy Volunteers","enrollment":36},{"nctId":"NCT04362527","phase":"PHASE3","title":"Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage","status":"COMPLETED","sponsor":"University Hospital, Angers","startDate":"2020-08-10","conditions":"Vasospasm","enrollment":370},{"nctId":"NCT07450430","phase":"PHASE3","title":"Optimal Timing of Ketamine Initiation for SCD Pain","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2026-02","conditions":"Sickle Cell Disease, Sickle Cell Crisis","enrollment":90},{"nctId":"NCT07102628","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-10-03","conditions":"Acute Coronary Syndrome","enrollment":300},{"nctId":"NCT07453602","phase":"PHASE1","title":"Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234","status":"RECRUITING","sponsor":"Arcutis Biotherapeutics, Inc.","startDate":"2026-03-02","conditions":"Atopic Dermatitis (AD), Eczema","enrollment":125},{"nctId":"NCT07118891","phase":"PHASE1, PHASE2","title":"Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause","status":"RECRUITING","sponsor":"AbCellera Biologics Inc.","startDate":"2025-06-23","conditions":"Vasomotor Symptoms Associated With Menopause, Healthy Volunteers","enrollment":136},{"nctId":"NCT05692180","phase":"PHASE3","title":"A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2023-04-05","conditions":"Asthma","enrollment":200},{"nctId":"NCT07435428","phase":"PHASE3","title":"A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows","status":"RECRUITING","sponsor":"Ipsen","startDate":"2026-02-18","conditions":"Moderate to Severe Glabellar Lines","enrollment":1300},{"nctId":"NCT05503264","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-09-27","conditions":"NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis","enrollment":152},{"nctId":"NCT07427797","phase":"PHASE3","title":"A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows","status":"RECRUITING","sponsor":"Ipsen","startDate":"2026-02-27","conditions":"Moderate to Severe Glabellar Lines","enrollment":300},{"nctId":"NCT07452822","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Topcel-KH Pharmaceutical Co., Ltd.","startDate":"2026-02-20","conditions":"Arteriovenous Fistula Stenosis","enrollment":54},{"nctId":"NCT07401472","phase":"PHASE1","title":"Study of BW-50218 in Healthy Participants","status":"RECRUITING","sponsor":"Shanghai Argo Biopharmaceutical Co., Ltd.","startDate":"2026-02-25","conditions":"Healthy Participants Study","enrollment":60},{"nctId":"NCT07210463","phase":"PHASE3","title":"A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)","status":"RECRUITING","sponsor":"Merz Aesthetics GmbH","startDate":"2025-10-01","conditions":"Neuromuscular Agents, Peripheral Nervous System Agents, Physiological Effects of Drugs","enrollment":300},{"nctId":"NCT07379580","phase":"PHASE2","title":"A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa","status":"RECRUITING","sponsor":"BioNTech SE","startDate":"2026-02-20","conditions":"Mpox (Monkeypox), Smallpox, Orthopoxvirus Infection","enrollment":310},{"nctId":"NCT07445919","phase":"PHASE2","title":"A Clinical Study to Evaluate SM17 for Atopic Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"SinoMab BioScience Ltd","startDate":"2026-04-05","conditions":"Atopic Dermatitis","enrollment":200},{"nctId":"NCT07445971","phase":"PHASE1","title":"A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.","status":"RECRUITING","sponsor":"ModeX Therapeutics, An OPKO Health Company","startDate":"2026-03","conditions":"COVID -19, COVID-19 (Prevention)","enrollment":80},{"nctId":"NCT06826196","phase":"PHASE1, PHASE2","title":"A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata","status":"RECRUITING","sponsor":"Aldena Therapeutics","startDate":"2025-03-24","conditions":"Alopecia Areata (AA)","enrollment":24},{"nctId":"NCT06036602","phase":"PHASE2","title":"Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy Adults","status":"COMPLETED","sponsor":"Albert B. Sabin Vaccine Institute","startDate":"2024-07-15","conditions":"Ebola Sudan Virus Disease","enrollment":125},{"nctId":"NCT07235046","phase":"PHASE2","title":"A Study of DII235 in Adults With Elevated Lipoprotein(a)","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-12-05","conditions":"Lipoprotein Disorder","enrollment":200},{"nctId":"NCT07185009","phase":"PHASE3","title":"A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis","status":"RECRUITING","sponsor":"Sanofi","startDate":"2026-01-16","conditions":"Ulcerative Colitis","enrollment":671},{"nctId":"NCT05674994","phase":"PHASE3","title":"Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Fondation Hôpital Saint-Joseph","startDate":"2023-10-26","conditions":"Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":110}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["benzocaine gel-lidocaine-epinephrine nerve block injection"],"phase":"phase_3","status":"active","brandName":"Placebo injectable solution","genericName":"Placebo injectable solution","companyName":"IBSA Institut Biochimique SA","companyId":"ibsa-institut-biochimique-sa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}